Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Bradley Glover resigned as Executive Vice President and Chief Operating Officer at Celularity Inc.
- Action
- resigned
- Role
- Executive Vice President and Chief Operating Officer
Exact text from the filing
Bradley Glover, Ph.D., Executive Vice President and Chief Operating Officer and principal operating officer of Celularity, notified Celularity of his decision to resign from his role effective as of May 31, 2023 to pursue another opportunity.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.99
Celularity Inc entered into Securities Purchase Agreement with several accredited investors valued at aggregate purchase price of approximately $3.75 million for 5,813,945 shares of Class A common stock (effective 2023-05-17).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- several accredited investors
- Value
- aggregate purchase price of approximately $3.75 million for 5,813,945 shares of Class A common stock
- Effective
- 2023-05-17
Exact text from the filing
On May 17, 2023, Celularity Inc., or Celularity, entered into a securities purchase agreement with several accredited investors, providing for the private placement of (i) 5,813,945 shares of its Class A common stock, par value $0.0001 per share, or the Class A common stock, and (ii) accompanying warrants to purchase up to 5,813,945 shares of Class A common stock, or the PIPE Warrants, for $0.52 per share and $0.125 per accompanying PIPE Warrant, for an aggregate purchase price of approximately $3.75 million.
View on SEC.gov